fluphenazine has been researched along with Cancer of Mouth in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Co-treatment with nelfinavir or lopinavir had a high sensitizing effect on vincristine-treated KBV20C cells." | 1.51 | Co-treatment With HIV Protease Inhibitor Nelfinavir Greatly Increases Late-phase Apoptosis of Drug-resistant KBV20C Cancer Cells Independently of P-Glycoprotein Inhibition. ( Kim, JY; Lee, BM; Park, YJ; Yoon, S, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, JY | 1 |
| Park, YJ | 1 |
| Lee, BM | 1 |
| Yoon, S | 1 |
1 other study available for fluphenazine and Cancer of Mouth
| Article | Year |
|---|---|
Co-treatment With HIV Protease Inhibitor Nelfinavir Greatly Increases Late-phase Apoptosis of Drug-resistant KBV20C Cancer Cells Independently of P-Glycoprotein Inhibition.
Topics: Antimitotic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, S | 2019 |